Envíe este artículo por correo electrónico 
Influencia del género en la migraña episódica, revisión de la literatura sobre características diferenciales entre hombres y mujeres en el contexto de la patología migrañosa
Resumen
DOI: https://doi.org/10.53766/AcBio/2024.14.28.19
Buscamos actualizar a los lectores sobre los avances recientes en nuestra comprensión del sexo y el género en la migraña episódica con una serie de dos partes. En la parte 1, examinamos la epidemiología de la migraña en el contexto del sexo y el género, las diferencias en la sintomatología y la influencia de las hormonas sexuales en la fisiopatología de la migraña (incluida la CGRP). En la parte 2, nos enfocamos en las consideraciones clínicas prácticas para el sexo y el género en la migraña episódica al abordar la migraña menstrual y el tema controvertido de las terapias que contienen hormonas. Tomamos nota de los datos aplicables a las poblaciones de minorías de género, cuando están disponibles, y resumimos el conocimiento sobre la terapia hormonal de afirmación de género y el manejo de la migraña en personas transgénero. Finalmente, abordamos brevemente las disparidades de salud, las consideraciones socioeconómicas y el sesgo de investigación.
Recibido: 02/05/2024
Aceptado: 14/05/2024
Palabras clave
Texto completo:
PDFReferencias
Money J, Hampson JG, Hampson JL. An examination of some basic sexual concepts: The evidence of human hermaphroditism. Bull Johns Hopkins Hosp. 1955;97(4):301–319. (PubMed) (Google Scholar)
Money J, Hampson JG, Hampson JL. Hermaphroditism: recommendations concerning assignment of sex, change of sex and psychologic management. Bull Johns Hopkins Hosp. 1955;97(4):284–300. (PubMed) (Google Scholar)
Money J, Hampson JG, Hampson JL. Imprinting and the establishment of gender role. AMA Arch Neurol Psychiatry. 1957;77(3):333–336. doi: 10.1001/archneurpsyc.1957.02330330119019. (PubMed) (CrossRef) (Google Scholar)
Association AP. Guidelines for Psychological Practice With Lesbian, Gay, and Bisexual Clients. Am Psychol. 2012;67:10–42. doi: 10.1037/a0024659. (PubMed) (CrossRef) (Google Scholar)
Suen LW, Lunn MR, Katuzny K, et al. What Sexual and Gender Minority People Want Researchers to Know About Sexual Orientation and Gender Identity Questions: A Qualitative Study. Arch Sex Behav. 2020;49(7):2301–2318. doi: 10.1007/s10508-020-01810-y. (PMC free article) (PubMed) (CrossRef) (Google Scholar)
Victor TW, Hu X, Campbell JC, Buse DC, Lipton RB. Migraine prevalence by age and sex in the United States: a life-span study. Cephalalgia. 2010;30(9):1065–1072. doi: 10.1177/0333102409355601. (PubMed) (CrossRef) (Google Scholar)
Steiner TJ, Stovner LJ, Jensen R, Uluduz D, Katsarava Z. on behalf of Lifting The Burden: the Global Campaign against, Migraine remains second among the world’s causes of disability, and first among young women: findings from GBD2019. J Headache Pain. 2020;21(1):137. 10.1186/s10194-020-01208-0. (PMC free article) (PubMed)
Lipton RB, Manack Adams A, Buse DC, Fanning KM, Reed ML. A Comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study: Demographics and Headache-Related Disability. Headache. 2016;56(8):1280–9. 10.1111/head.12878. (PMC free article) (PubMed)
Adams AM, Serrano D, Buse DC, et al. The impact of chronic migraine: The Chronic Migraine Epidemiology and Outcomes (CaMEO) Study methods and baseline results. Cephalalgia : an international journal of headache. 2015;35(7):563–578. doi: 10.1177/0333102414552532. (PMC free article) (PubMed) (CrossRef) (Google Scholar)
Silberstein S, Loder E, Diamond S, Reed ML, Bigal ME, Lipton RB. Probable migraine in the United States: results of the American Migraine Prevalence and Prevention (AMPP) study. Cephalalgia. 2007;27(3):220–229. doi: 10.1111/j.1468-2982.2006.01275.x. (PubMed) (CrossRef) (Google Scholar)
Buse DC, Loder EW, Gorman JA, et al. Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of the American Migraine Prevalence and Prevention (AMPP) Study. Headache. 2013;53(8):1278–1299. doi: 10.1111/head.12150. (PubMed) (CrossRef) (Google Scholar)
Ly DP, Jena AB. Sex differences in time spent on household activities and care of children among US physicians, 2003–2016. Mayo Clin Proc. 2018. Elsevier. (PMC free article) (PubMed)
Yavorsky JE, Kamp Dush CM, Schoppe-Sullivan SJ. The production of inequality: The gender division of labor across the transition to parenthood. J Marriage Fam. 2015;77(3):662–679. (PMC free article) (PubMed)
Dowson AJ, Kilminster SG, Salt R, Clark M, Bundy MJ. Disability associated with headaches occurring inside and outside the menstrual period in those with migraine: a general practice study. Headache J Head Face Pain. 2005;45(4):274–282. (PubMed)
Lipton RB, Fanning KM, Buse DC, et al. Migraine progression in subgroups of migraine based on comorbidities: results of the CaMEO study. Neurology. 2019;93(24):e2224–e2236. doi: 10.1212/WNL.0000000000008589. (PMC free article) (PubMed) (CrossRef) (Google Scholar)
Lipton RB, Munjal S, Alam A, et al. Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences. Headache J Head Face Pain. 2018;58(9):1408–1426. 10.1111/head.13407. (PubMed)
Buse D, Kovacik AJ, Nicholson RA, et al. Acute Treatment Optimization Influences Disability and Quality of Life in Migraine: Results of the ObserVational survey of the Epidemiology, tReatment and Care Of MigrainE (OVERCOME) Study (4154) Neurology. 2020;94(15 Supplement):4154. (Google Scholar)
Rosendale N, Wong JO, Flatt JD, Whitaker E. Sexual and Gender Minority Health in Neurology: A Scoping Review. JAMA Neurol. 2021. This recent review identifies key deficiencies in the neurologic literature on sexual and gender minority populations. (PMC free article) (PubMed)
Pringsheim T, Gooren L. Migraine prevalence in male to female transsexuals on hormone therapy. Neurology. 2004;63(3):593–594. doi: 10.1212/01.WNL.0000130338.62037.CC. (PubMed) (CrossRef) (Google Scholar)
Buse DC, Reed ML, Fanning KM, et al. Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study. J Headache Pain. 2020;21(1):23. doi: 10.1186/s10194-020-1084-y. (PMC free article) (PubMed) (CrossRef) (Google Scholar)
Bolay H, Ozge A, Saginc P, et al. Gender influences headache characteristics with increasing age in migraine patients. Cephalalgia. 2015;35(9):792–800. doi: 10.1177/0333102414559735. (PubMed) (CrossRef) (Google Scholar)
Buse DC, Loder EW, Gorman JA, et al. Sex Differences in the Prevalence, Symptoms, and Associated Features of Migraine, Probable Migraine and Other Severe Headache: Results of the American Migraine Prevalence and Prevention (AMPP) Study. Headache J Head Face Pain. 2013;53(8):1278–1299. 10.1111/head.12150. (PubMed)
Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S. Pathophysiology of Migraine: A Disorder of Sensory Processing. Physiol Rev. 2017;97(2):553–622. doi: 10.1152/physrev.00034.2015. (PMC free article) (PubMed) (CrossRef) (Google Scholar)
Dodick DW. A phase-by-phase review of migraine pathophysiology. Headache J Head Face Pain. 2018;58:4–16. (PubMed)
Somerville BW. The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology. 1972;22(4):355–365. doi: 10.1212/wnl.22.4.355. (PubMed) (CrossRef) (Google Scholar)
MacGregor E, Frith A, Ellis J, Aspinall L, Hackshaw A. Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen. Neurology. 2006;67(12):2154–2158. doi: 10.1212/01.wnl.0000233888.18228.19. (PubMed) (CrossRef) (Google Scholar)
Martin VT, Wernke S, Mandell K, et al. Defining the Relationship Between Ovarian Hormones and Migraine Headache. Headache J Head Face Pain. 2005;45(9):1190–1201. 10.1111/j.1526-4610.2005.00242.x. (PubMed)
Pavlovic JM, Allshouse AA, Santoro NF, et al. Sex hormones in women with and without migraine: Evidence of migraine-specific hormone profiles. Neurology. 2016;87(1):49–56. doi: 10.1212/wnl.0000000000002798. (PMC free article) (PubMed) (CrossRef) (Google Scholar)
Lichten EM, Lichten JB, Whitty A, Pieper D. The confirmation of a biochemical marker for women's hormonal migraine: The depo-estradiol challenge test. Headache J Head Face Pain. 1996;36(6):367–371. (PubMed)
van Oosterhout WPJ, Schoonman GG, van Zwet EW, et al. Female sex hormones in men with migraine. Neurology. 2018;91(4):e374–e381. doi: 10.1212/wnl.0000000000005855. (PubMed) (CrossRef) (Google Scholar)
Gupta S, Villalón CM, Mehrotra S, et al. Female sex hormones and rat dural vasodilatation to CGRP, periarterial electrical stimulation and capsaicin. Headache J Head Face Pain. 2007;47(2):225–235. (PubMed)
Eikermann-Haerter K, Dileköz E, Kudo C, et al. Genetic and hormonal factors modulate spreading depression and transient hemiparesis in mouse models of familial hemiplegic migraine type 1. J Clin Investig. 2009;119(1):99–109. (PMC free article) (PubMed) (Google Scholar)
MacGregor EA. Oestrogen and attacks of migraine with and without aura. The Lancet Neurology. 2004;3(6):354–361. doi: 10.1016/S1474-4422(04)00768-9. (PubMed) (CrossRef) (Google Scholar)
Chuang S-H, Reddy DS. 3ß-methyl-neurosteroid analogs are preferential positive allosteric modulators and direct activators of extrasynaptic d-subunit ?-aminobutyric acid type A receptors in the hippocampus dentate gyrus subfield. J Pharmacol Exp Ther. 2018;365(3):583–601. doi: 10.1124/jpet.117.246660. (PMC free article) (PubMed) (CrossRef) (Google Scholar)
Reddy DS. Neurosteroids: endogenous role in the human brain and therapeutic potentials. Prog Brain Res. 2010;186:113–137. doi: 10.1016/B978-0-444-53630-3.00008-7. (PMC free article) (PubMed) (CrossRef) (Google Scholar)
Reddy DS. Role of neurosteroids in catamenial epilepsy. Epilepsy Res. 2004;62(2–3):99–118. doi: 10.1016/j.eplepsyres.2004.09.003. (PubMed) (CrossRef) (Google Scholar)
Rustichelli C, Bellei E, Bergamini S, et al. Serum levels of allopregnanolone, progesterone and testosterone in menstrually-related and postmenopausal migraine: A cross-sectional study. Cephalalgia. 2020;40(12):1355–1362. doi: 10.1177/0333102420937742. (PMC free article) (PubMed) (CrossRef) (Google Scholar)
Glaser R, Dimitrakakis C, Trimble N, Martin V. Testosterone pellet implants and migraine headaches: A pilot study. Maturitas. 2012;71(4):385–388. doi: 10.1016/j.maturitas.2012.01.006. (PubMed) (CrossRef) (Google Scholar)
Lichten EM, Bennett RS, Whitty AJ, Daoud Y. Efficacy of danazol in the control of hormonal migraine. J Reprod Med. 1991;36(6):419–424. (PubMed) (Google Scholar)
Shields LBE, Seifert T, Shelton BJ, Plato BM. Testosterone levels in men with chronic migraine. Neurol Int. 2019;11(2):8079–8079. doi: 10.4081/ni.2019.8079. (PMC free article) (PubMed) (CrossRef) (Google Scholar)
Eikermann-Haerter K, Baum MJ, Ferrari MD, van den Maagdenberg AM, Moskowitz MA, Ayata C. Androgenic suppression of spreading depression in familial hemiplegic migraine type 1 mutant mice. Ann Neurol. 2009;66(4):564–568. doi: 10.1002/ana.21779. (PMC free article) (PubMed) (CrossRef) (Google Scholar)
Fink G, Sumner B, Rosie R, Wilson H, McQueen J. Androgen actions on central serotonin neurotransmission: relevance for mood, mental state and memory. Behav Brain Res. 1999;105(1):53–68. doi: 10.1016/S0166-4328(99)00082-0. (PubMed) (CrossRef) (Google Scholar)
Perusquía M, Stallone JN. Do androgens play a beneficial role in the regulation of vascular tone? Nongenomic vascular effects of testosterone metabolites. American Journal of Physiology-Heart and Circulatory Physiology. 2010;298(5):H1301–H1307. doi: 10.1152/ajpheart.00753.2009. (PMC free article) (PubMed) (CrossRef) (Google Scholar)
Fargo KN, Foecking EM, Jones KJ, Sengelaub DR. Neuroprotective actions of androgens on motoneurons. Front Neuroendocrinol. 2009;30(2):130–141. doi: 10.1016/j.yfrne.2009.04.005. (PMC free article) (PubMed) (CrossRef) (Google Scholar)
Cairns BE, Gazerani P. Sex-related differences in pain. Maturitas. 2009;63(4):292–296. doi: 10.1016/j.maturitas.2009.06.004. (PubMed) (CrossRef) (Google Scholar)
MacGregor A. Estrogen replacement and migraine aura. Headache J Head Face Pain. 1999;39(9):674–678. (PubMed)
Borsook D, Erpelding N, Lebel A, et al. Sex and the migraine brain. Neurobiol Dis. 2014;68:200–214. doi: 10.1016/j.nbd.2014.03.008. (PMC free article) (PubMed) (CrossRef) (Google Scholar)
Martin VT, Lee J, Behbehani MM. Sensitization of the trigeminal sensory system during different stages of the rat estrous cycle: implications for menstrual migraine. Headache J Head Face Pain. 2007;47(4):552–563. (PubMed)
Labastida-Ramírez A, Rubio-Beltrán E, Villalón CM, MaassenVanDenBrink A. Gender aspects of CGRP in migraine. Cephalalgia. 2019;39(3):435–444. doi: 10.1177/0333102417739584. (PMC free article) (PubMed) (CrossRef) (Google Scholar)
Gupta S, Mehrotra S, Villalón C, et al. Effects of female sex hormones on responses to CGRP, acetylcholine, and 5-HT in rat isolated arteries. Headache J Head Face Pain. 2007;47(4):564–575. (PubMed)
Sandweiss AJ, Cottier KE, McIntosh MI, et al. 17-ß-Estradiol induces spreading depression and pain behavior in alert female rats. Oncotarget. 2017;8(69):114109. doi: 10.18632/oncotarget.23141. (PMC free article) (PubMed) (CrossRef) (Google Scholar)
Ibrahimi K, Vermeersch S, Frederiks P, et al. The influence of migraine and female hormones on capsaicin-induced dermal blood flow. Cephalalgia. 2017;37(12):1164–1172. doi: 10.1177/0333102416668659. (PubMed) (CrossRef) (Google Scholar)
Downie J, Poyser N, Wunderlich M. Levels of prostaglandins in human endometrium during the normal menstrual cycle. J Physiol. 1974;236(2):465–472. doi: 10.1113/jphysiol.1974.sp010446. (PMC free article) (PubMed) (CrossRef) (Google Scholar)
Jang Y, Kim M, Hwang SW. Molecular mechanisms underlying the actions of arachidonic acid-derived prostaglandins on peripheral nociception. J Neuroinflammation. 2020;17(1):30. doi: 10.1186/s12974-020-1703-1. (PMC free article) (PubMed) (CrossRef) (Google Scholar)
Stevenson JC, Macdonald D, Warren RC, Booker MW, Whitehead MI. Increased concentration of circulating calcitonin gene related peptide during normal human pregnancy. Br Med J (Clin Res Ed) 1986;293(6558):1329–1330. doi: 10.1136/bmj.293.6558.1329. (PMC free article) (PubMed) (CrossRef) (Google Scholar)
Yallampalli C, Chauhan M, Thota CS, Kondapaka S, Wimalawansa SJ. Calcitonin gene-related peptide in pregnancy and its emerging receptor heterogeneity. Trends Endocrinol Metab. 2002;13(6):263–269. doi: 10.1016/S1043-2760(02)00563-5. (PubMed) (CrossRef) (Google Scholar)
Gupta P, Harte A, Sturdee D, et al. Effects of menopausal status on circulating calcitonin gene-related peptide and adipokines: implications for insulin resistance and cardiovascular risks. Climacteric. 2008;11(5):364–372. doi: 10.1080/13697130802378493. (PubMed) (CrossRef) (Google Scholar)
Delaruelle Z, Ivanova TA, Khan S, et al. Male and female sex hormones in primary headaches. J Headache Pain. 2018;19(1):1–12. doi: 10.1186/s10194-018-0922-7. (PMC free article) (PubMed) (CrossRef) (Google Scholar)
Vetvik KG, MacGregor EA. Menstrual migraine: a distinct disorder needing greater recognition. Lancet Neurol. 2021;20(4):304–315. doi: 10.1016/s1474-4422(20)30482-8. (PubMed) (CrossRef) (Google Scholar)
MacGregor EA. Migraine in pregnancy and lactation: a clinical review. BMJ Sexual & Reproductive Health. 2007;33(2):83. (PubMed) (Google Scholar)
Wang SJ, Fuh JL, Lu SR, Juang KD, Wang PH. Migraine prevalence during menopausal transition. Headache J Head Face Pain. 2003;43(5):470–478. (PubMed)
Mattsson P. Hormonal factors in migraine: A population-based study of women aged 40 to 74 years. Headache J Head Face Pain. 2003;43(1):27–35. (PubMed)
Couturier E, Bomhof M, Neven AK, Van Duijn N. Menstrual migraine in a representative Dutch population sample: prevalence, disability and treatment. Cephalalgia. 2003;23(4):302–308. doi: 10.1046/j.1468-2982.2003.00516.x. (PubMed) (CrossRef) (Google Scholar)
Stewart WF, Lipton R, Chee E, Sawyer J, Silberstein S. Menstrual cycle and headache in a population sample of migraineurs. Neurology. 2000;55(10):1517–1523. doi: 10.1212/WNL.55.10.1517. (PubMed) (CrossRef) (Google Scholar)
Cupini L, Matteis M, Troisi E, et al. Sex-hormone-related events in migrainous females. A clinical comparative study between migraine with aura and migraine without aura. Cephalalgia. 1995;15(2):140–144. (PubMed)
Granella F, Sances G, Pucci E, Nappi R, Ghiotto N, Nappi G. Migraine with aura and reproductive life events: a case control study. Cephalalgia. 2000;20(8):701–707. doi: 10.1046/j.1468-2982.2000.00112.x. (PubMed) (CrossRef) (Google Scholar)
Sheftell FD, Zatochill MK, Szeto M, et al. Development of a simple menstrual migraine screening tool for obstetric and gynecology clinics. In Obstetrics and Gynecology. 2008. Lippincott Williams & Wilkins 530 Walnut St, Philadelphia. (PubMed)
Russell M, Rasmussen B, Fenger K, Olesen J. Migraine without aura and migraine with aura are distinct clinical entities: a study of four hundred and eighty-four male and female migraineurs from the general population. Cephalalgia. 1996;16(4):239–245. doi: 10.1046/j.1468-2982.1996.1604239.x. (PubMed) (CrossRef) (Google Scholar)
Vetvik KG, MacGregor EA, Lundqvist C, Russell MB. Prevalence of menstrual migraine: a population-based study. Cephalalgia. 2014;34(4):280–288. doi: 10.1177/0333102413507637. (PubMed) (CrossRef) (Google Scholar)
Edelman A, Micks E, Gallo MF, Jensen JT, Grimes DA. Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception. Cochrane Database Syst Rev. 2014;(7). (PMC free article) (PubMed)
DOI: https://www.doi.org/10.53766/AcBio/Se encuentra actualmente indizada en: | |||
 |  |  |  |
  |  |  |  |
 |  |  |  |
 |  | ||
Todos los documentos publicados en esta revista se distribuyen bajo una
Licencia Creative Commons Atribución -No Comercial- Compartir Igual 4.0 Internacional.
Por lo que el envío, procesamiento y publicación de artículos en la revista es totalmente gratuito.